||Key Players-Merck KGaA, Bayer AG, IGENOMIX, Eve Medical, Mitsubishi Tanabe Pharma Corporation & Others
Data Bridge Market Research has announced the addition of new statistical data titled as, Global Miscarriage Market . It is scrutinized with various aspects of the existing industries such as types, size, application, and end-users.Across the globe, some significant global regions such as North America, Latin America, Asia-Pacific, Europe, and India. The major industry key players have been profiled to get complete analysis of successful strategies adopted by the top-level key Players. On the other hand, it evaluates various economic facts of the companies such as shares, profit margins to understand the financial terms effectively. The first class miscarriage market report is a window to the industry which explains what market definition, classifications, applications, engagements and market trends are. By keeping end users at the centre point, a team of researchers, forecasters, analysts and industry experts work exhaustively to formulate this market research report. miscarriage market is supposed to grow during the forecast period due to growing demand at the end user level. According to this market report, new highs will take place in the market in 2021-2028. Global miscarriage market research report offers the best professional in-depth study on the current state for the healthcare industry. The miscarriage market is expected to witness market growth at a rate of 4% in the forecast period of 2021 to 2028. Data Bridge Market Research report on miscarriage market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-miscarriage-market
The major players covered in the miscarriage market report are
ILTOO Pharma, Fertility SA,
Global Miscarriage Market Drivers:
The rise in the utilization of birth control pills is escalating the growth of miscarriage market. Miscarriage can be known as impulsive ending of a pregnancy. About half of the miscarriage happens within the first trimester before 20 week’s gestations. Recurrent miscarriage continues can be a difficult reproductive challenge for the patient and clinician. Major factors that are expected to boost the growth of the miscarriage market in the forecast period are rise in the incidence of smoking and alcohol among women. Furthermore, the growing of the incidence of diabetes and thyroid disorders is further anticipated to propel the growth of the miscarriage market. On the other hand, the dearth of alertness among the women regarding the miscarriage is further projected to impede the growth of the miscarriage market in the timeline period. Global Miscarriage Market Restraints:
In addition, the increase in the healthcare expenses in the advancing countries will further provide potential opportunities for the growth of the miscarriage market in the coming years. However, the rise in the price of treatment might further challenge the growth of the miscarriage market in the near future. Insights of the Study
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the trocars market
Market Penetration: Comprehensive information on the product portfolios of the top players in the Miscarriage market
To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders
The key findings and recommendations highlight crucial progressive industry trends in the Miscarriage Market, thereby allowing players to develop effective long term strategies
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals. Make An Enquiry and Ask For Report@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-miscarriage-market
The study objectives of this report are:
To study and forecast the market size in global Miscarriage
To analyze the global key players, market value, and global market share for top participants of the Miscarriage market by employing SWOT analysis. To classify, illustrate, and forecast the market by type, end use, and region. To analyze the market while comparing and forecasting its status between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of the World. To analyze the market potential and advantage, opportunity and challenge, restraints and risks for all the global key regions. To recognize noteworthy trends and factors driving or inhibiting the market growth. To evaluate the market opportunities available for stakeholders by discovering the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. To study competitive developments such as expansions, new product launches, agreements, and acquisitions in the market. Miscarriage Market Scope and Market Size
The miscarriage market is segmented on the basis of type, drugs, diagnosis, treatment, route of administration, distribution channel and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of types, the miscarriage market is segmented into complete miscarriage, incomplete miscarriage, missed miscarriage, threatened miscarriage, inevitable miscarriage and septic miscarriage. On the basis of drugs, the miscarriage market is segmented into misoprostol, mifepristone, methotrexate, progesterone and others. On the basis of diagnosis, the miscarriage market is segmented into pelvic exam, tissue test, chromosomal test, ultrasound and blood test. On the basis of treatment, the miscarriage market is segmented into medication, surgery, supportive care and others. On the basis of route of administration, the miscarriage market is segmented into  oral , vaginal and others. On the basis of distribution channel, the miscarriage market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. On the basis of end users, the miscarriage market is segmented into hospitals, homecare, specialty clinics and others. List of Chapters: 
3 Global Miscarriage Capacity, Production, Revenue (Value) by Region (2021-2028)
4 Global Miscarriage Supply (Production), Consumption, Export, Import by Region (2021-2028)
5 Global Miscarriage Production, Revenue (Value), Price Trend by Type
6 Global Miscarriage Market Analysis by Application
7 Global Miscarriage Manufacturers Profiles/Analysis
8 Miscarriage Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Miscarriage Market Forecast (2021-2028)
13 Research Findings and Conclusion
14 Appendix
The core objectives of this report are:
To analyze the status, future forecast, growth opportunity, key market factors, and key players in the global miscarriage market. To present the development of Miscarriage market in the United States, Europe, and China. To summarize the key players tactically and analyze their development plans and strategies comprehensively. To reveal and forecast the market by product type, market and key regions. To discuss the future aspects impacting the global Miscarriage market in every possible way. To study the competition of market providers based on the factors such as innovation, reputation, pricing, service, promotion, and distribution. To gather the most important data from the research while arranging it in a proper manner so that the analysis is more efficient and effective. Reasons to Purchase Miscarriage  Market Report Covered:
The report gives an examination about how Miscarriage market will develop in the future. It studies a range of views of the Miscarriage market with the help of Porter’s five forces analysis. This market report analyzes the product type that is supposed to control the market and regions that are likely to witness the fastest development during the forecast period. It discovers the new developments, Miscarriage market shares and strategies employed by the key market players. It studies the competitive landscape including the market share of major players along with the key strategies accepted for growth in the past five years. The report provides whole company profiles covering the product offerings, key financial information, current developments, SWOT analysis and strategies employed by the major Miscarriage market players. About Us: 
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing  sopan.gedam@databridgemarketresearch.com  . We are content with our glorious 99.9 % client satisfying rate. Contact:

Global Miscarriage Market 2021:Trends,Size,Regional Analysis, Industry Scenario,Forecast To 2028||Key Players-Merck KGaA, Bayer AG, IGENOMIX, Eve Medical, Mitsubishi Tanabe Pharma Corporation & Others

Eight Ventures Including NF Venture Eve Medical Selected by the SheEO Network for Funding
2019
The newest eight ventures selected by the SheEO network for funding this year have been announced. The SheEO network and SheEO Ventures are taking on the world's to-do list, which means their business models and outcomes help achieve the UN's Sustainable Development Goals (SDGs). Leading up to the summit, the newest founders spent the weekend at a retreat with their Development Guides. One of the unique features of the SheEO model is that the Ventures decide amongst themselves how to allocate the $800,000 fund. Mar 13, 2019
Satish Kanwar, Director of Product, Shopify
“The scale and quality of meet-ups and conferences and speaking events have gone up dramatically. You don’t need to leave Toronto to build a successful company.”
Evgeny Tchebotarev, Co-Founder, 500px
"If you come to our studio and take a look at the people sitting around the table discussing ideas, they’re from almost every part of the world. I think  it has really helped Umbra create an international style.”
Paul Rowan, Co-Founder and VP Inspiration, Umbra
"A culture of collaboration is really at the heart of what’s next in innovation. What’s exciting in Toronto is that we have local and international businesses  partnering with the startup ecosystem and increasingly with the academic community to position themselves for success in the future. And it’s happening across the spectrum from digital media and information technology, to life sciences and healthcare, energy solutions and social innovation.”
Dr. Ilse Treurnicht, CEO, MaRS Discovery District
"Toronto is emerging as a technology hub and attracting increased investment,  including ours, because of forward thinking government and amazing access to technology, an incredible talent pool and leading educational institutions, as well as industries and markets in healthcare and financial services.”
Dr. Rick Huijbregts, Vice-President, Industry Transformation, Cisco Canada
“I think it’s an attractive place to come for talented people, it's a huge market for creative people and I think there are some companies emerging that give people hope that it can be done here.”
Mike McDerment, CEO/Co-Founder, Freshbooks
“In Toronto, Bombardier manufactures business and commercial aircraft and relies on the diversified, local regional supply chain. We work with more than 70 suppliers located in the Greater Toronto Area and we benefit from a variety of expertise going from complex machining to systems integration.”
Graham Kelly, Vice-President, Global Operations & Toronto Site, Bombardier Aerospace
"Startups in Toronto benefit from support at every stage. From the very early stage we have incubators, accelerators and seed stage investors. In the growth stage, we have funders willing to invest a lot of money to really help a company take-off. This gives tech companies in Toronto a huge advantage.”
Allen Lau, CEO & Co-Founder, Wattpad
/

Eight Ventures Including NF Venture Eve Medical Selected by the SheEO Network for Funding

The Canadian government is dedicating $5.47 million in 12 projects through its Health Technologies Fund through 2018, which supports partnerships between publicly funded health service providers, patients, academia, and industry. Through the fund, the Office of the Chief Health Innovation Strategist identifies health priorities that groups can work on. The focus is on encouraging more integrated care between the home and health institution, and many of the projects leverage technology to improve outcomes. Toronto-based MedChart , a platform that allows patients to aggregate their medical records from health care providers across the country, is part of the CAREchart@home project with partners like the Princess Margaret Cancer Centre, Sunnybrook Hospital, and Bayshore Healthcare. The project will allow patients at five partner hospitals to control sharing their data using after-hours cancer care telemedicine by Bayshore Homecare. This project received $497,620. Eve Medical, which develops a self-sampling device and mailer box that allows women to collect their own samples to test for HPV and cervical cancer, is participating in a project that received $469,001 with Women’s College Hospital, Aboriginal Health Access Centre, and Mount Sinai Hospital. The project will allow women to collect their own samples, see results online through a secure portal within a week, and follow up with a health professional. NexJ Health, Homecare Intelligence, and m-Health Solutions are also among the companies participating. A full list of the projects is available here .

MedChart, Eve Medical part of healthtech projects funded by $5.47 million from Ontario

By Amira Zubairi Canadian Startup News March 31, 2017
Eve Medical’s Jessica Ching calls on men to be “allies” in conversations of diversity in tech
At the latest HealthTO, Eve Medical CEO and co-founder Jessica Ching spoke about her company’s product and what it’s like being a woman founder in Canada’s tech community. Ching said she launched Eve Medical to make female health screenings easier, simpler, and more accessible for the average woman, especially since women often “cringe” at the thought of being tested for health concerns like HPV or cervical cancer. To encourage more women to get screened, Ching designed HerSwab, a self-sampling device and mailer box that allows women to collect their own samples for molecular diagnostics testing. Women can order an “EveKit” online and collect and send back samples using HerSwab, which are then processed at an accredited lab. If the results are positive, users can access licensed physicians to follow-up. Ching said the startup is solving a common pain point for women: access to a clinic. “A lot of the reasons are simple. Women don’t go because they don’t have time, they don’t have transportation, and they don’t have childcare,” said Ching, adding that it ends up costing the health care system because who aren’t screened can end up with preventable diseases. “We came up with a lot of different ideas about how this product could work and most importantly, we went to women themselves with our prototypes and asked them to hold it, to use it, to give us feedback,” said Ching. “[It’s] a two-step process that women can do very easily.”
Along with explaining Eve Medical’s products, Ching also reflected on being a female founder in light of International Women’s Day. “I don’t necessarily feel like I’m any different than any other founder because I’m doing the same things,” said Ching. “I’m putting in the hours…I’m building my team. I’m building my product. There’s nothing about what I’m doing that’s different from what a male founder would do.”
Even though she doesn’t feel a difference from other founders, Ching said there’s still work to be done in bridging the gender gap in tech, citing a report that only three percent of female founders receive VC funding. She stressed the importance for men to “be allies” to women. “Men are really important to this equation too,” said Ching. “When the conversations come up about women in tech when the question is asked, ‘what does an entrepreneur look like to you’ — take a stand and support the other women entrepreneurs around you.”
Watch the full presentation below:

Eve Medical’s Jessica Ching calls on men to be “allies” in conversations of diversity in tech

facebook google twitter linkedin
Jessica Ching, Co-founder & CEO, Eve Medical
Jessica Ching attended OCAD University with the full intention of becoming an industrial designer and no real intention of becoming an entrepreneur—that is, until she had to do a thesis project in her fourth year. She was having a conversation with a group of women and the topic of cervical cancer came up. The general consensus was that the experience of getting tested for cervical cancer was uncomfortable and, as a result, many women do not get checked. Jessica decided that she wanted to find a solution to this problem. She turned what was at first her thesis into Eve Medical , a company specializing in creating medical devices specifically for women’s healthcare needs. “Designers are not really the first people who come to mind when you think about healthcare,” Jessica says. “But the whole focus of industrial design is making things usable for people.”
That’s precisely what Eve Medical has done to the screening process for human papillomavirus (HPV) and sexually transmitted infections (STIs), infections that may lead to cervical cancer. With guidance from Sharon Walmsley, senior scientist at Toronto General Research Institute, and Joan Murphy, clinical lead of the Ontario Cervical Screening Program at Cancer Care Ontario, Jessica developed the prototype for Eve Medical’s first product, HerSwab . HerSwab enables women to collect samples in the comfort of their own home to screen for common STIs. Jessica hopes the device will be a stepping stone to encourage women to test for preventable infections. “If [the result] was positive then they could go follow up at a clinic, which would bring people back into the healthcare system,” she says. How it works
HerSwab was just the first step. Eve Medical recently launched an IndieGogo campaign for the prelaunch of Eve Kit, a home-testing kit that includes HerSwab as the collection device. The kit can be ordered online and is delivered to the user’s home. The user collects the sample, fills out a short questionnaire to specify what infections they want to test for and sends the kit back to Eve Medical. The company then sends the sample to a lab for processing and delivers the results back to the user. “The focus is really to make the process very friendly and to make it not feel like a medical process or product,” says Jessica. “We want to feel more like a wellness solution or a consumer cosmetic product.”
The results of the company’s clinical study at McMaster University proved how user-friendly the self-collection system is. The company surveyed almost 200 women who tried HerSwab. Over 90% of those surveyed reported that HerSwab was easy to use and approximately 80% said they preferred this collection method to the physician-collected method. Test and refine
Arriving at such positive results required a lot of testing and refining. As a startup in the healthcare sector, it was arguably harder for Eve Medical to mobilize than it is for startups in other spaces, says Jessica. “The upfront capital requirements are much higher and the development times are much longer,” she explains. For example, the Eve Medical team had to make changes to the design of the HerSwab device based on user feedback. “You’re supposed to test your product and then refine, but the problem is that the testing cycle is so long,” says Jessica. “For other startups, like apps or web-based applications, it’s easier to refine your product very quickly.”
Not to mention the fact that Jessica did not have a background in science, so there was a steep learning curve. Fortunately, the hard work paid off. Eve Medical was one of five finalists for the 2016 Quest Award, which challenged startups around the world to find solutions to end cervical cancer. The company won second place in the Life Science Nation Redefining Early Stage Investments Conference Innovation Challenge held in San Francisco in January 2016. Going global
In five years, Jessica hopes to see Eve Kits being used by women all over the world. “We’re already a global company,” says Jessica, “but we’ve set a target for ourselves to be screening five million women in 2020.”
Currently, Eve Medical offers HerSwab kits in 12 countries, including Slovenia, Italy, Mexico and Spain, and is doing pilots in six more. “I think about the time we’ve taken to develop our product until now and about how many women have not been doing anything in that time, and I feel that sense of urgency that we need to get this out there so that women can start using it,” says Jessica. Isabelle Docto
Isabelle is a communications intern at MaRS. See more…
Filed Under


#HumansofMaRS: Eve Medical enables women to test for cervical cancer from the comfort of their own homes

Startups focused on providing products and services catering to women's health and wellbeing.

Women's Health & Wellness

These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.

Beauty & Personal Care

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Medical Devices

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Cancer

Health IT 

Loan

Eve Medical is the medical device company behind HerSwab, an easy to use, reliable way for women to screen for the infection that causes cervical cancer.

Wells Fargo Success Story

Professional Services

Platform Overview

Eve Medical

Compete with Eve Medical?

Compete with Eve Medical?

Discover the right solution for your team